Dec 22, 2020
On a Saturday afternoon in March as COVID-19 was bearing down on New York City, a dozen scientists anxiously crowded around a computer in a suburban drug company’s lab. They had spent weeks frantically getting blood from early survivors across the globe and from mice with human-like immune systems all to test thousands of potential treatments.
Now it was time for results.
The screen flashed totals of glowing green dots, hundreds or thousands in most samples. Then they saw some 10s, some twos and finally, zeroes.
The researchers cheered and their boss sent out for champagne.
No dots meant no infected cells. The scientists had found antibodies that block the coronavirus.
Regeneron s quest for a COVID-19 antibody drug
japantimes.co.jp - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from japantimes.co.jp Daily Mail and Mail on Sunday newspapers.
One company s quest for an antibody drug to fight COVID-19
americanpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from americanpress.com Daily Mail and Mail on Sunday newspapers.
On a Saturday afternoon in March as Covid-19 was bearing down on New York City, a dozen scientists anxiously crowded around a computer in a suburban drug company’s lab. They had spent weeks frantically getting blood from early survivors across the globe and from mice with human-like immune systems all to test thousands of potential treatments. Now it was time for results. The screen flashed totals of glowing green dots, hundreds or thousands in most samples. Then they saw some 10s, some twos and finally, zeroes. The researchers cheered and their boss sent out for champagne. No dots meant no infected cells. The scientists had found antibodies that block the coronavirus.
Marilynn Marchione
In this Friday, March 13, 2020 photo provided by Regneron, members of the Infectious Disease team celebrate at their lab in New York state after confirming cells from Singapore are viable and that some make antibodies that bind to the coronavirus, suggesting they may have the potential to block it. (Regeneron via AP) December 20, 2020 - 9:06 PM
On a Saturday afternoon in March as COVID-19 was bearing down on New York City, a dozen scientists anxiously crowded around a computer in a suburban drug companyâs lab. They had spent weeks frantically getting blood from early survivors across the globe and from mice with human-like immune systems â all to test thousands of potential treatments.